Press Releases

February 2, 2024 Lupin Launches Cyanocobalamin Nasal Spray in the United States

February 1, 2024 Lupin Receives Approval from U.S. FDA for Dronedarone Tablets, USP

January 30, 2024 Lupin Digital Health introduces Digital Therapeutics Certificate for Cardiologists in India in collaboration with the American College of Cardiology

January 23, 2024 Lupin Receives Tentative Approval from U.S. FDA for Rivaroxaban Tablets USP

January 18, 2024 Lupin Receives Approval from U.S. FDA for Febuxostat Tablets

January 14, 2024 Lupin Hosts Second Edition of Aptivate Champion Run for Kids

January 14, 2024 Lupin Receives Approval from U.S. FDA for Propranolol Hydrochloride Extended-Release Capsules USP

January 10, 2024 Lupin Launches Varenicline Tablets in the United States

January 9, 2024 Lupin Launches Bromfenac Ophthalmic Solution, 0.07% in the United States